HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies
Crossref DOI link: https://doi.org/10.1007/s10456-016-9510-0
Published Online: 2016-05-04
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Subhani, Saima
Vavilala, Divya Teja
Mukherji, Mridul
Text and Data Mining valid from 2016-05-04